Elevated neutrophil‐to‐lymphocyte ratio predicts poor outcome in patients with advanced non‐small‐cell lung cancer receiving first‐line gefitinib or erlotinib treatment
Gui‐Nan Lin; Jie‐Wen Peng; Pan‐Pan Liu; Dong‐Ying Liu; Jian‐jun Xiao; Xiao‐Qin Chen
Author Information: Department of Medical Oncology
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.